Live from the NIH registry
Studies recruiting near Aurora right now
Top 25 of 1,561 recruiting studies, sorted by proximity — each links to its official registry page
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 45 participants sought
Children's Hospital Colorado — Aurora, Colorado (5.9 mi)
· Sponsor: University of Colorado, Denver
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Children's Hospital Colorado — Aurora, Colorado (5.9 mi)
· Sponsor: Nationwide Children's Hospital
Mode of Exercise and Bone Biomarkers in Older Veterans
Aging, Musculoskeletal Diseases
N/A
Interventional 120 participants sought
Rocky Mountain Regional VA Medical Center, Aurora, CO — Aurora, Colorado (5.9 mi)
· Sponsor: VA Office of Research and Development
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Colorado — Aurora, Colorado (5.9 mi)
· Sponsor: National Cancer Institute (NCI)
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
SCRI Denver Drug Development Unit — Denver, Colorado (14.0 mi)
· Sponsor: Acepodia Biotech, Inc.
Type 1 Diabetes REst for Metabolic Health
Type 1 Diabetes (T1D), Sleep Health
N/A
Interventional 50 participants sought
Children's Hospital Colorado — Aurora, Colorado (5.9 mi)
· Sponsor: University of Colorado, Denver
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Denver, Colorado (14.0 mi)
· Sponsor: Dren Bio
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis
N/A
Observational 380 participants sought
Children'S Hospital of Colorado — Denver, Colorado (14.0 mi)
· Sponsor: University of Colorado, Denver
Effects of High Altitude on AMPK Activation
Pregnancy, IUGR
N/A
Observational 84 participants sought
University of Colorado Denver Anschutz Medical Campus — Aurora, Colorado (5.9 mi)
· Sponsor: University of Colorado, Denver
International Weight Control Registry
Weight Loss, Overweight
N/A
Observational 100,000 participants sought
University of Colorado, Denver — Denver, Colorado (14.0 mi)
· Sponsor: Tufts University
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Colorado Denver — Aurora, Colorado (5.9 mi)
· Sponsor: Jaeb Center for Health Research
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Rocky Mountain Cancer Centers (RMCC) ( Site 8001) — Aurora, Colorado (5.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Aurora, Colorado (5.9 mi)
· Sponsor: Sameek Roychowdhury
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Barbara Davis Center for Childhood Diabetes — Aurora, Colorado (5.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
Genetic Regulators of Bone Health That Are Unique to Vertebral Bone
Age-Related Osteoporosis
N/A
Observational 550 participants sought
Univeristy of Colorado Denver — Aurora, Colorado (5.9 mi)
· Sponsor: University of Colorado, Denver
BeSMART Secure Storage Counseling in the Inpatient Setting
Firearm Injury, Safety Issues
N/A
Interventional 400 participants sought
Children's Hospital Colorado — Aurora, Colorado (5.9 mi)
· Sponsor: Vanderbilt University Medical Center
Cannabidiol and Cannabis Concentrate Users
Cannabis Use Disorder
Phase 2
Interventional 120 participants sought
University of Colorado Anschutz Medical Campus — Aurora, Colorado (5.9 mi)
· Sponsor: University of Colorado, Denver
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
IgA Nephropathy
Phase 2
Interventional 25 participants sought
Clinical Research Site 330 — Denver, Colorado (14.0 mi)
· Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Children's Hospital Colorado — Aurora, Colorado (5.9 mi)
· Sponsor: Nationwide Children's Hospital
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center — Aurora, Colorado (5.9 mi)
· Sponsor: Bayer
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Aurora, Colorado (5.9 mi)
· Sponsor: Daiichi Sankyo
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Rocky Mountain Cancer Centers-Aurora — Aurora, Colorado (5.9 mi)
· Sponsor: SWOG Cancer Research Network
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
University of Colorado — Aurora, Colorado (5.9 mi)
· Sponsor: Guardant Health, Inc.
PRC With Meniscal Allograft Arthroplasty for Wrist Osteoarthritis
Wrist Osteoarthritis
N/A
Interventional 20 participants sought
UCHealth Steadman Hawkins Clinic Inverness — Englewood, Colorado (14.7 mi)
· Sponsor: University of Colorado, Denver
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Ovarian Cancer, Advanced Ovarian Carcinoma
N/A
Interventional 240 participants sought
University of Colorado Cancer Center-Anschutz — Aurora, Colorado (5.9 mi)
· Sponsor: Dana-Farber Cancer Institute